TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
TAK

Takeda Pharmaceutical Co Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

17.40$ -0.1% vs. previous close Closing price · As of: Aug 13, 2026

Ownership

Ownership Structure

Who owns Takeda Pharmaceutical Co Ltd (TAK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.1%

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings TAK
Person Role Shares Value As of Type
Plump Andrew Stewart President, R&D 766,569 13,338,301 $ Aug 10, 2026 direct
Kim Julie So-Young President and CEO 391,489 6,811,909 $ Aug 10, 2026 direct
Platford Giles Richard President, IBU 315,838 5,495,581 $ Aug 10, 2026 direct
Bitetti Teresa Marie President, OBU 252,010 4,384,974 $ Aug 10, 2026 direct
Duprey Lauren Rusckowski Chief Transformation Officer 226,057 3,933,392 $ Aug 10, 2026 direct
Furney Natalie Anne Marie Global General Counsel 204,298 3,554,785 $ Aug 10, 2026 direct
Pacheco Rhonda Janice President, U.S. Business Unit 182,507 3,175,622 $ Aug 10, 2026 direct
Pignagnoli Agosti Marcello Head, Strat. & Port. Dev 176,977 3,079,400 $ Aug 10, 2026 direct
Ricci Gabriele Chief Data & Tech. Officer 171,654 2,986,780 $ Aug 10, 2026 direct
Farajallah Awny Samaan Botros Chief Medical Officer 116,177 2,021,480 $ Aug 10, 2026 direct
Ibrahim Ramy Riad Ahmed President, PDT BU 102,588 1,785,031 $ Aug 10, 2026 direct
Shannon Elaine Mary Pres., Global Supply & Quality 67,311 1,171,211 $ Aug 11, 2026 direct
Greenway Nicola Deidre Petal Chief Human Resources Officer 53,029 922,705 $ Aug 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 11, 2026 Shannon Elaine Mary Pres., Global Supply & Quality Sell 20,363 17.55 357,371
Aug 10, 2026 Farajallah Awny Samaan Botros Chief Medical Officer Sell 14,006 17.10 239,503
Aug 10, 2026 Ibrahim Ramy Riad Ahmed President, PDT BU Sell 7,277 17.10 124,437
Aug 10, 2026 Pacheco Rhonda Janice President, U.S. Business Unit Sell 16,901 17.10 289,007
Aug 10, 2026 Duprey Lauren Rusckowski Chief Transformation Officer Sell 47,586 17.10 813,721
Aug 10, 2026 Plump Andrew Stewart President, R&D Sell 165,393 17.10 2,828,220
Aug 10, 2026 Pignagnoli Agosti Marcello Head, Strat. & Port. Dev Sell 22,957 17.10 392,565
Aug 10, 2026 Bitetti Teresa Marie President, OBU Sell 50,012 17.10 855,205
Aug 10, 2026 Shannon Elaine Mary Pres., Global Supply & Quality Sell 3,978 17.10 68,024
Aug 10, 2026 Ricci Gabriele Chief Data & Tech. Officer Sell 25,088 17.10 429,005
Aug 10, 2026 Greenway Nicola Deidre Petal Chief Human Resources Officer Sell 6,774 17.10 115,835
Aug 10, 2026 Kim Julie So-Young President and CEO Sell 89,090 17.10 1,523,439
Aug 10, 2026 Platford Giles Richard President, IBU Sell 31,083 17.10 531,519
Aug 10, 2026 Furney Natalie Anne Marie Global General Counsel Sell 30,868 17.10 527,843
Aug 10, 2026 Greenway Nicola Deidre Petal Chief Human Resources Officer Sell 33,628 17.51 588,715
Aug 10, 2026 Greenway Nicola Deidre Petal Chief Human Resources Officer Sell 975 17.50 17,063

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?